The NXDC-MEN-301 Study on 5-ALA for Meningiomas Surgery: An Innovative Study Design for the Assessing the Benefit of Intra-Operative Fluorescence Imaging

The NXDC-MEN-301 Study on 5-ALA for Meningiomas Surgery: An Innovative Study Design for the Assessing the Benefit of Intra-Operative Fluorescence Imaging

Background: 5-aminolevulinic acid (5-ALA; Gleolan<sup>TM</sup>, NX Development Corps., Lexington, USA) is approved for fluorescence-guided resections of suspected malignant gliomas. Experience has demonstrated that meningiomas also show fluorescence, which may be a useful surgical adjunc...

Full description

Bibliographic Details
Main Authors: Walter Stummer, Markus Holling, Bernard R. Bendok, Michael A. Vogelbaum, Ashley Cox, Sara L. Renfrow, Georg Widhalm, Alan Ezrin, Salvatore DeSena, Murray L. Sackman, Joseph W. Wyse
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Brain Sciences
Subjects:
fluorescence imaging study
neurooncological surgery
5-ALA
meningioma
fluorescence-guided resection
clinical trials
Online Access:https://www.mdpi.com/2076-3425/12/8/1044

Internet

https://www.mdpi.com/2076-3425/12/8/1044

Similar Items